The Vanguard Group, Inc. recently announced the acquisition of new stake in Texas Instruments Inc. (NASDAQ:TXN). The institutional investor has increased its shareholding in the Technology company by 0.49% to 84.93 million shares with purchase of 0.41 million shares. This fresh investment now brings its stake to 9.35% valued currently at $14.48 billion. In addition, BlackRock Fund Advisors raised its holdings by 0.37 million to 53.34 million shares. And Capital Research & Management Co has lifted its position by 60.75% or 10.36 million shares – to 27.43 million shares.
Currently, there are 908.20M common shares owned by the public and among those 906.93M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 51 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 30 of these insider trades were purchases, accounting for 239,177 shares. Insider sales of the common stock occurred on 21 occasions, with total insider shares sold totaling 99,669 shares.
The top 3 mutual fund holders in Texas Instruments Inc. are Vanguard Total Stock Market ETF, Vanguard 500 Index Fund, and Invesco QQQ Trust. Vanguard Total Stock Market ETF owns 28.48 million shares of the company’s stock, all valued at over $4.86 billion. The company bought an additional 36780.0 shares recently to bring their total holdings to about 3.14% of the shares outstanding. Vanguard 500 Index Fund bought 48026.0 shares to see its total holdings expand to 22.18 million shares valued at over $3.78 billion and representing 2.44% of the shares outstanding. Invesco QQQ Trust sold 42862.0 shares to bring its total holdings to over 16.7 million shares at a value of $2.85 billion. Invesco QQQ Trust now owns shares totaling to 1.84% of the shares outstanding.
The company’s stock has a 5-day price change of 4.86% and 14.38% over the past three months. TXN shares are trading 1.87% year to date (YTD), with the 12-month market performance down to -0.06% lower. It has a 12-month low price of $139.48 and touched a high of $188.12 over the same period. TXN has an average intraday trading volume of 5.71 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.78%, 8.75%, and 4.68% respectively.
Institutional ownership of Texas Instruments Inc. (NASDAQ: TXN) shares accounts for 86.76% of the company’s 908.20M shares outstanding. Mutual fund holders own 34.74%, while other institutional holders and individual stakeholders account for 52.77% and 0.55% respectively.
It has a market capitalization of $157.71B and a beta (3y monthly) value of 1.04. The stock’s trailing 12-month PE ratio is 22.51, while the earnings-per-share (ttm) stands at $7.71. The company has a PEG of 2.25 and a Quick Ratio of 4.22 with the debt-to-equity ratio at 0.67. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.18% over the week and 1.73% over the month.
Analysts forecast that Texas Instruments Inc. (TXN) will achieve an EPS of $1.46 for the current quarter, $1.41 for the next quarter and $6.56 for 2024. The lowest estimate earnings-per-share for the quarter is $1.36 while analysts give the company a high EPS estimate of $1.52. Comparatively, EPS for the current quarter was $2.13 a year ago. Earnings per share for the fiscal year are expected to decrease by -25.03%, and -9.06% over the next financial year. EPS should shrink at an annualized rate of 10.00% over the next five years, compared to 21.11% over the past 5-year period.
Looking at the support for the TXN, a number of firms have released research notes about the stock. UBS stated their Buy rating for the stock in a research note on January 19, 2024, with the firm’s price target at $170-$195.
